Adverse plaque characteristics (APCs) by coronary computed tomography (CT) angiography (CTA) are associated with myocardial ischaemia and future acute coronary syndromes. The overall objective was to determine whether APCs on non-invasive CTA are associated with vulnerable plaque features by invasive optical coherence tomography (OCT).
Introduction
Histopathological studies on subjects who have experienced sudden cardiac death suggest the pathogenesis of the majority of acute coronary events to be related to occlusive thrombus formation after disruption of a thin-cap fibroatheroma (TCFA) overlying a large necrotic lipid core. 1, 2 These 'vulnerable plaques' are also often characterized by both intraplaque and systemic inflammation that are critical to this process. 3 Extensive ex vivo and in vitro evidence link local macrophage infiltration with vulnerable plaque characteristics, 1,2,4 with histopathological evidence of intense macrophage infiltration localized at the site of the thin fibrous cap. 5, 6 Optical coherence tomography (OCT) is an intravascular imaging method that enables coronary artery plaque characterization by the highest achievable in vivo spatial resolution at 10-20 mm, a resolution of 10-fold higher than that of intravascular ultrasound (IVUS). 7, 8 A prior study has demonstrated OCT to be a reliable and accurate for characterization of high-risk plaque features, including thickness of fibrous cap and intraplaque lipid arcs. 9 Macrophages can also be visualized by OCT and are seen as signal-rich, distinct, or confluent punctate regions that exceed the intensity of background speckle noise. 8, 10 Coronary computed tomography (CT) angiography (CTA) is a non-invasive test that enables direct visualization of coronary artery disease (CAD) and correlates favourably with invasive angiography for measures of stenosis severity. 11 CTA also permits assessment of coronary atherosclerotic plaque morphology and composition in general concordance with intravascular ultrasonography. 12, 13 Coronary plaque characteristics visualized by CTAincluding positive remodelling (PR), low attenuation plaque (LAP), spotty calcification (SC), and a 'napkin-ring' sign-have been associated with myocardial ischaemia and markers of future acute coronary syndromes (ACS). 14, 15 Whether these adverse plaque characteristics (APCs) are associated with high-risk plaque features by OCT has not been adequately examined to date. Furthermore, it is difficult to routinely perform intravascular assessment of coronary plaque in a large number of patients. Thus, the overall objective was to determine whether APCs on non-invasive CTA are associated with high-risk plaque features when compared with an invasive OCT reference standard.
Methods
Consecutive patients who underwent clinically indicated CTA and were observed to have at least one CTA-determined ≥50% stenosis in the proximal or mid portion of a major epicardial coronary artery were referred for invasive coronary angiography (ICA). At ICA, OCT was prospectively performed in CTA-determined lesions (between 25 and 90% stenosis) for research purpose. Exclusion criteria included: chronic kidney disease, left main CAD; vessel tortuosity ≥908; and ST-segment elevation myocardial infarction. Patients presenting with unstable angina or non-ST-segment elevation myocardial infarction were eligible for study entry. Study patients underwent OCT within 3 months of CTA without an intervening coronary event and change in medications. In 45 patients, 68 lesions were evaluated by CTA and OCT. Baseline characteristics of the study population are listed in Table 1 . The mean interval between CTA and OCT was 31 + 23 days.
Prior to CTA, we prospectively ascertained the presence of CAD risk factors. Hypertension was defined as blood pressure ≥140/90 mmHg or use of anti-hypertensive drugs. Hyperlipidaemia was defined as a present or past history of low-density lipoprotein-cholesterol level ≥140 mg/dL, or use of cholesterol-lowering medications. Diabetes mellitus was defined as a fasting blood glucose .126 mg/dL or haemoglobin A1c ≥6.4%, or use of anti-diabetic medications. The present study was performed at two centres (Kobe University Graduate School of Medicine and Kobe Circulation Clinic). The Institutional Review Board of the study centres approved the study and all patients provided written informed consent.
CTA was performed using 128-detector row CT (Somatom Definition AS+ TM , Forchheim, Germany) or 320-detector row CT (Toshiba Aquilion One TM , Otawara, Japan) in accordance with societal guidelines. 16 An intravenous bolus (30 -90 mL) of contrast agent (Omnipaque TM 350 mg/dL, Daiichi-Sankyo, Tokyo, Japan or Iomeron TM 350 mg/dL, Eizai, Tokyo, Japan) was injected at a flow rate of 0.07 mL/kg/s. The scan parameters included 64 × 0.5 mm collimation, tube current time product of 300 -400 ms per rotation, tube voltage 100 or 120 kVp for 320-detector row CT; 64 × 0.6 mm collimation, tube current time product of 300 ms per rotation, tube voltage 100 or 120 kVp for 128-detector row CT. Scans were performed using ECGbased tube current modulation whenever possible, or sequential image acquisition. Transaxial images were reconstructed with 0.75-/0.5-mm slice thickness and 0.3-/0.5-mm slice increment using a medium-smooth convolution kernel. An estimated effective radiation dose for CTA ranged from 2 to 10 mSv.
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Each CTA-identified plaque was quantified manually by an experienced imager (initial experience for Level 3 by the Society of Cardiovascular Computed Tomography) blinded to OCT results in accordance with societal guidelines. 18 To ensure that CTA-identified plaques were those identical to OCT, an independent cardiologist identified anatomical landmarks (e.g. side branches and bifurcations) to select the proximal and distal fiduciary points for CTA and OCT analysis. After identification of plaques referenced to fiduciary markers, contiguous cross-sectional reconstructions were rendered along a vessel centreline using a slice thickness of 1.0 mm and an increment of 0.5 mm on a dedicated 3D workstation (AW Advantage; GE Healthcare, Waukesha, WI, USA).
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In order to enable optimal and consistent detection of plaque and outer vessel boundaries, window width was set at 155% of the mean intensity within the lumen and window level was set at 65% of the mean intensity for each lesion, as we have previously described. 20 Diameter stenosis (%) and area stenosis (%) were calculated using proximal and distal reference segments, respectively, which were selected to be adjacent to the maximal stenosis in which there was minimal or no plaque. Haemoglobin A1C (%) 6.1 + 0.8
Values are mean + SD or n (%).
maximum stenosis. We evaluated the CT attenuation values in each plaque lesions on cross-sectional images. For each plaque, greater than or equal to three rounded regions of interest (ROIs) of 0.5 mm 2 were placed within the target lesions, and the lowest CT density value (Hounsfield units, HU) was recorded as a CT attenuation value. For plaques with calcified components, ROIs were placed within non-calcified regions. The outer vessel contour was defined as the visualized border, with lumen areas traced in each cross-section. A remodelling index was defined as the ratio of the outer vessel area at the most stenotic segment divided by the outer vessel area at a proximal reference segment. 21 Furthermore, we evaluated the presence of APCs for each plaque: PR, remodelling index ≥1.10; LAP, any intraplaque voxel ,30 HU; SC, any discrete calcification ≤3 mm in length and occupying ≤908 arc when viewed in short axis. 22 We also evaluated the presence of a 'napkin-ring sign', which was defined as the presence of low CT attenuation in the centre of a plaque close to the lumen circumscribed by a rim area with higher attenuation. 15 Images were acquired using a commercially available frequencydomain OCT system (C7-XR OCT Intravascular Imaging System, St Jude Medical, St Paul, MN, USA), and performed in a standard fashion. 23 In brief, a 2.7-Fr OCT imaging catheter (Dragonfly, LightLab
Imaging, Inc.) was advanced distal to the lesion, with automatic pullback initiated concordantly with blood clearance. Each coronary vessel was imaged with automated pullback at 15 mm/s, and OCT data were recorded on a CD-ROM for off-line analysis.
A signal-rich homogenous lesion overlying lipid content was diagnosed as a fibrous cap. 7, 24, 25 The thinnest part of the fibrous cap was measured three times and the average value calculated. Based on prior criteria, we considered any coronary lesion with a fibrous cap thickness ,65 mm and a lipid arc .908 to be diagnostic of TCFA. 2 OCT evidence of a signal-poor lesion with an unclear border was considered diagnostic of a lipid core, with .908 vs. ≤908 of the circumference of the vessel recorded. Intraplaque macrophage infiltration was diagnosed by a superficial highintensity signal band underlying a low signal area. 8 Plaque vulnerability was graded by OCT in an increasing fashion as plaques having no TCFA, TCFA without macrophage infiltration, or TCFA with macrophage infiltration. Using the proprietary software (LightLab Imaging, Inc.), OCT data were analysed at an independent core laboratory by an experienced investigator blinded to ICA, CTA, and clinical data. Our laboratory's intra-and interobserver reproducibility data for OCT and CTA imaging have been reported previously. 20, 25 Continuous variables were expressed as mean + SD. For three group comparisons, a one-way ANOVA test with Scheffe correction for multiple pair-wise comparisons was used for continuous variables; and Pearson x 2 test or Fisher exact test was used as appropriate for categorical variables. Prevalence of OCT plaque features was evaluated by the x 2 test for trend. Inter-and intraobserver variability for OCT-derived macrophage detection was assessed by the Kappa test. Uni-and multivariable logistic regression analyses were performed to evaluate the relationship between CT parameters and OCT plaque features. To examine discrimination, area under the receiver operating characteristic (AUC) curves were constructed and compared for different CTA parameters. 26 Associations and differences with P-values of ,0.05 were considered significant. Statistical analyses were performed using the STATA software (version 11, StataCorp LP, College Station, TX, USA).
Results
By OCT, lesions were: those without TCFA (n ¼ 44), TCFA without macrophage infiltration (n ¼ 7), and TCFA with macrophage infiltration (n ¼ 17; Table 3 , which included PR or LAP, increasing remodelling index, lower CT attenuation value, greater diameter stenosis, and smaller MLD. The napkin-ring sign was not an independent predictor for TCFA with macrophage. In multivariable models considering age and gender, PR [odds ratio (OR) 16.9, 95% confidence interval (CI) 3.9 -73.3, P , 0.001] or LAP (OR 11.2, 95% CI 2.8 -44.3, P ¼ 0.001) were strongly associated with TCFA with macrophage ( Table 3) . Furthermore, in multivariable logistic regression analysis also considering % diameter stenosis, PR (OR 12.3, 95% CI 2.4 -62.5, P ¼ 0.002) or LAP (OR 6.9, 95% CI 1.2 -39.4, P ¼ 0.03), higher remodelling index (OR 1.1, 95% CI 1.0 -1.2, P ¼ 0.006), and lower CT attenuation values (OR 0.9, 95% CI 0.97-0.99, P ¼ 0.04) were independent predictors of TCFA with macrophage.
AUC for TCFA with macrophage was highest for higher remodelling index was 0.85 (95% CI 0.75-0.94, P , 0.0001). AUC was 0.77 (95% CI 0.63-0.90, P , 0.001) for a decreasing CT attenuation value, 0.75 (95% CI 0.57-0.92, P ¼ 0.003) for % diameter stenosis; 0.62 (95% CI 0.46-0.78, P ¼ 0.06) for % area stenosis; 0.69 (95% CI 0.52-0.87, P ¼ 0.01) for MLD; and 0.59 (95% CI 0.44-0.74, P ¼ 0.12) for MLA. AUC was 0.77 (95% CI 0.65 -0.90, P ¼ 0.001) for PR; 0.73 (95% CI 0.60-0.86, P ¼ 0.0003) for LAP; 0.56 (95% CI 0.46-0.66, P ¼ 0.12) for SC; and 0.56 (95% CI 0.45-0.67, P ¼ 0.15) for napkin-ring sign. Figure 2 represents the example of CTA and OCT image for a lesion of TCFA with macrophage.
Discussion
In the current study of individuals undergoing CTA, ICA, and OCT, we observed that increasing plaque vulnerability grade by OCT was associated with an increasing number of APCs as well as individual APCs by CTA, including PR and LAP. We observed a particularly strong relationship between PR and LAP by CTA to TCFA with macrophage, both for diagnosis and for discrimination. Even when adjusted for conventional angiographic measures of CAD severity-including % diameter stenosis-these relations remained independent and additive. Collectively, these present results suggest the utility of APCs as an effective method for CTA evaluation of CAD beyond stenosis severity for enhanced identification of high-risk coronary plaques. By virtual histology IVUS, the PROSPECT (Providing Regional Observations to Study Predictors of Events in the Coronary Tree) study evaluated coronary lesions in the proximal-to-mid-portions of major epicardial arteries from patients undergoing uncomplicated percutaneous coronary intervention after presentation of ACS. 27 At a 3-year follow-up, nearly half of subsequent ACS events were associated with non-culprit lesions. The majority of these lesions were observed to be angiographically mild, confirming previous data presented by Falk et al. 28 In PROSPECT, numerous atherosclerotic plaque characteristics beyond stenosis severity were observed to be important in the ACS process, including large plaque burden, smaller MLA, and TCFA. Note, however, that, the positive predictive value of plaque characteristics remains very low in absolute terms in the PROSPECT study. CTA enables a non-invasive assessment of atherosclerotic plaque characteristics within arterial walls, with general agreement to invasive methods. Several prior reports have evaluated the value of CT-based APC identification-including PR, LAP, and SC-for identification of culprit lesions at the time of presentation of ACS. Hoffmann et al. 29 first reported that culprit lesions identified at the time of ACS demonstrated higher rates of PR and non-calcified plaque, when compared with culprit lesions in patients with stable angina pectoris. These findings were confirmed by Motoyama et al.
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, in a large retrospective CTA study that culprit lesions of ACS possessed a higher prevalence of PR, LAP, and typically had SC; findings confirmed by Kitagawa et al. 30 In the sole prospective CTA study to date, Motoyama et al. 31 reported that the PR and LAP conferred a .20-fold higher hazards for subsequent ACS in a 27-month follow-up. The data from the present study both confirm as well as add to these important investigations by use of an intravascular 'gold' standard method with the highest achievable in vivo spatial resolution to permit the association of CTA APCs to TCFA, lipid angles, and macrophage infiltration. Interestingly, preliminary studies that have employed CTA to identify OCT-identified plaque morphologies for lesions that do vs. do not possess TCFA have reported conflicting findings. 32 remodelling indexes, and a 'ring-like' enhancement appearance of coronary plaques to be predictors of TCFA. Our present study results are more consistent with the latter of these studies, but are directly additive to their important results by evaluating intravascular imaging criteria of intraplaque inflammation in addition to TCFA. We observed the strongest relation of CTA-identified PR to TCFA by OCT, findings that are in agreement with those reported by Raffel et al. 35 Many potential mechanisms exist to explain these findings, including PR to be potentially associated with higher atheroma volume or a compensatory state that promotes endothelial dysfunction. It appears likely that these morphological APCs-that is, PR and LAP-identified by CTA are, in fact, inter-related. We observed not only a strong association between individual APCs and plaque vulnerability grade by OCT, but also a dose-response relationship as well wherein multiple APCs appeared to confer a higher probability of vulnerable plaque by OCT when compared with a single APC. Our study findings are in contradistinction with a recent ex vivo study by Maurovich-Horvat, who reported that a napkin-ring sign has significantly improved diagnostic accuracy for the detection of TCFA as adjudicated by histopathology. 15 In our study, napkin-ring sign was not associated with TCFA with macrophage by OCT.
There are a number of potential explanations for our findings. Given the need for fixation of arterial specimens in prior ex vivo studies, the preparation process may have influenced the CT appearance of the studied atherosclerotic plaques. In contrast, in our in vivo study, we employed a standardized method for the evaluation of coronary plaques in order to ensure uniformity of assessment. We have previously described this method to be that which demonstrates the highest diagnostic accuracy compared with IVUS. 20 Yet, additional differences in study performance-including differences in iodinated contrast opacification of coronary plaques, or calcified plaque components-may exist. Future studies evaluating the diagnostic performance of CTA to identify 'napkin-ring' signs, as well as their prognostic potential, now appear warranted and are currently being pursued by our laboratory. The findings of the present study carry high clinical import. Current interpretation methods of CTA endorsed by societal guidelines generally limit recommendations of CTA reporting to findings related to angiographic measures of stenosis severity. Yet, in addition to our present study findings, CTA assessment of the morphological components of coronary plaques has been demonstrated to be associated with myocardial ischaemia and future ACS. The findings of the present study provide insights into the anatomical and inflammatory mechanisms that may explain these findings wherein these plaque features-including PR and LAP-are strongly and directly associated with OCT plaque characteristics that are well accepted as 'vulnerable' in nature. It seems reasonable to consider extending CTA interpretation to include these features, with routine reporting of these findings in addition to measures of stenosis severity.
Limitations
This study is not without limitations. The present study sample was small owing to the invasive nature of evaluation by OCT, which emphasizes the need for more non-invasive methods for coronary plaque assessment that permit evaluation of greater sample sizes. It is, in part, for this reason that we are aiming to determine the relationship of a non-invasive method (CT) to the invasive reference standard (OCT). Furthermore, we examined a consecutive cohort of patients for plaque features that are generally associated with plaque rupture. As such, the findings of study should be applied to other potential mechanisms of ACS with caution, as recent evidence suggests that the plaque morphologies by CTA for ACS may not be routinely detectable. 36 Although there were no intervening coronary events or changes on medications between CTA and OCT, the change in the nature of characteristics (such as macrophage) could not be excluded. Finally, the endpoints examined in the present study were for atherosclerotic plaque features considered to be high risk. Thus, the clinical outcomes evidence is lacking and the clinical value of the present findings is a bit limited. Although our study findings may enhance the diagnostic potential of CTA for identification of these anatomically high-risk characteristics, future large-scale prospective studies examining the relationship of APCs to incident adverse outcomes should be performed, and our laboratory is currently pursuing such investigations.
Conclusion
Atherosclerotic plaque features by CTA, including positive arterial remodelling and LAP, are associated with coronary lesions that possess TCFA and macrophage infiltration. CTA may serve a role as a potential non-invasive method to identify high-risk plaques.
